Synovial sarcoma

Acta Orthopaedica Scandinavica

Volumn 71, Issue 2, 2000, Pages 1-28

  Skytting, Björn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1442297182     PISSN: 00016470     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/000164700753767944     Document Type: Article

References (80)

1. de Alva E, Kawai A, Healey J H, Fligman I, Meyers P A, Huvos A G, Gerald W L, Jhanwar S C, Argani P. Antonescu C R, Pardo-Mindan F J, Ginsberg J, Womer R, Lawlar E R, Wunder J, Andrulis I, Sorensen P H B, Barr F G, Ladanyi M. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 1998; 16: 1248 – 55.
2. Bergh P, Meis-Kindblom J M, Gherlinzoni F, Berlin O, Bacchini P, Bertoni F, Gunterberg B, Kindblom L-G. Synovial sarcoma. Identification of high and low risk groups. Submitted to Cancer.
3. Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional acti-vator localised in nuclear bodies. Hum. Mol. Genet; 1997: 6: 1559 – 64.
4. Broders A C, Hargrave R, Meyerding H W. Pathological features of soft tissue fibrosarcoma with special refer-ence to the grading of its malignancy. Surg Gynecol Ob-stet 1939; 69: 267 – 80.
5. Brodsky J T, Burt M E, Hajdu S I, Casper E S, Brennan M F. Tendosynovial sarcoma. Clinicopathologic features, treatment, and prognosis. Cancer 1992; 70: 484 – 9.
6. Brown D C, Gatter K C. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990; 17: 489 – 503.
7. de Bruijn D H R, Baats E, Zechner U, De Leeuw B, Bale-mans M, Olde-Weghuis D, Hirning-Folz U, van Kessel A. Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcoma. Oncogene 1996; 13: 643 – 8.
8. Boel P, Wildmann C, Sensi, M L, Brasseur R, Renauld J C, Coulie P, Boon T, van der Bruggen P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995; 2: 167 – 75.
9. Cadman N L, Soule E H, Kelly P J. Can-cer 1965; 18: 613 – 23.
10. Cagle LA, Mirra J M, Storm K, Roe D J, Eilber F R. Histo-logic Fetaures Relating to Prognosis in Synovial Sarco-ma. Cancer 1987; 59: 1910 – 4.
11. Cameron H U, Kostuik J P. A long-term follow-up of syn-ovial sarcoma. J Bone Joint Surg Am 1974; 56B: 613 – 7.
12. Cattoretti G, Becker M H G, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against re-combinant parts of the Ki-67 antigen (M1B1 and MIB3) detect proliferating cells in microwave-processed for-malin-fixed paraffin sections. J Pathol 1992; 168: 357 – 63.
13. Choong P F M, Pritchard D J, Sim F H, Rock M G, Nasci-mento A G. Long-term survival in high grade soft tissue sarcoma: prognostic factors in synovial sarcoma. Int J Oncol 1995; 7: 161 – 9.
14. Clark J, Rocques P J, Crew A J, Gill S, Shipley J, Chan A M. Identification of novel genes, SYT and SSX, in-volved in the t(X;18)(p11. 2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994; 7: 502 – 8.
15. Cordon-Cardo C, Latres E, Drobnjak M, Oliva M R, Pollak D, Woodruff J M, Marechal V, Chen J, Brennan M F, Levine A J. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994; 54: 794 – 9.
16. Crew A J, Clark J, Fisher C, Gill S, Grimer R, Chand A. Fusion of SYT to two genes, SSX1 and 55X2, encoding proteins with homology to the Kruppel- associated box in human synovial sarcoma. EMBO J 1995; 14: 2333 – 40.
17. Drobnjak M, Latres E, Pollak D, Karpeh M, Dudas M, Woodruff J M, Brennan M F, Cordon-Cardo C. Prognos-tic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarco-mas. JNCI 1994; 86: 549 – 54.
18. Ellis P S J, Whitehead R. Mitosis counting: a need for re-appraisel. Hum Pathol 1981; 12: 3 – 4.
19. El-Naggar A K, Ayala A G, Abdul-Karim F W, McLemore D, Ballance W W, Garney L, Ro J Y, Batsakis J G. Syn-ovial sarcoma. A DNA flow cytometric study. Cancer 1990; 65: 2295 – 300.
20. El-Rifai W, Larramendy M L, Björkvist A, Hemmer S, Kn-uutila S. Optimization of comparative genomic hybrid-ization using fluorochrome conjugated to dCTP and dUTP. Lab Invest 1997; 77: 699 – 700.
21. Enneking W F, Spanier S S, Goodman M A. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980; 153: 106 – 20.
22. Enzinger F M and Weiss S W. Soft tissue tumors. 3' ed. C V Mosby Co, St Louis, Toronto, London 1995.
23. Fligman I, Lonardo F, Jhanwar S C, Gerald W L, Woodruff J, Ladanyi M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-55X2 fusion tran-script. A J P 1995; 147: 1592 – 9.
24. Folpe A L, Schmidt R A, Chapman D, Gown A M. Poorly differentiated synovial sarcoma. Immunohistochemica 1 distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol. 1998; 22: 673 – 82.
25. Gerdes J, Lemke H, Baisch H, Wacker H H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-asso-ciated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710 – 5.
26. Gerdes J, Becker M H G, Key G. Immunohistochemica 1 detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992; 168: 85 – 7.
27. Golouh R, Vuzevski V, Bracko M, van der Heul R O, Cervek J. Synovial sarcoma: a clinicopathological study of 36 cases. J Surg Oncol 1990; 45: 20 – 8.
28. Gure A O, Tureci B, Sahin U, Tsang S, Scanlan M J, Jager E, Knuth A, Pfreundschuh M, Old L J, Chen Y-T. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997; 72: 965 – 71.
29. Gustafson P, Dreinhöfer K E, Rydholm A. Soft tissue sar-coma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 1994; 1: 47 – 50.
30. Gustafson P. Soft tissue sarcoma. Acta Orthop Scand. (Suppl 259) 1994; 65: 1 – 31.
31. Haagensen C D, Staut A P. Ann Surg 1944; 120: 826 – 42.
32. Hajdu S I, Shui M H, Fortner J G. Tendosynovial sarcoma. Cancer 1977; 39: 1201 – 17.
33. Heslin M J, Cordon-Cardo C, Lewis J J, Woodruff J M, Brennan M F. Ki-67 detected by M1B-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer 1998; 83: 490 – 7.
34. Janz M, De Leeuw B, Weghuis D O, Werner M, Nolte M, Geurts van Kessel A. Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma. J Pathol 1995; 175: 391 – 6.
35. Kallioniemi O P, Kallioniemi A, Piper J, Isola J, Waldman F M, Gray J W, Pinkel D. Optimizing comparative ge-nomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 1994; 10: 231 – 43.
36. Kampe C E, Rosen G, Eilber F, Eckardt J, Lowenbraun S, Foster J, Forscher C, Selch M. A study of intensive chemotherapy in 14 patients with lo-calized disease. Cancer 1993; 72: 2161 – 9.
37. Kawai A, Woodruff J, Healey J H, Brennan M, Antonescu C, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998; 338: 153 – 60.
38. Ladenstein R, Treuner J, Koscielniak E, d Oleire F, Keim M. Synovial sarcoma of childhood and adolescence. Re-port of the German CWS-81 study. Cancer 1993; 71: 3647 – 55.
39. de Leeuw B, Suijkerbuijk R F, Olde Weghuis D, Meloni A M. Distinct Xp11.2 breakpoint regions in synovial sar-coma revealed by metaphase and interphase FISH: rela-tionship to histologic subtypes. Cancer Genet Cytogenet 1994; 73: 89 – 94.
40. de Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A. Identification of two alternative fusion genes, SYT-SSX1 and SYT-55X2, in t(X;18)(p11.2;q11.2) - positive synovial sarcomas. Hum Mol Genet 1995; 6: 1097 – 9.
41. de Leeuw B, Balemans M, Geurts van Kessel A. A novel Kr:uppel-associated box containing the SSX gene (55X3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas. Cytogenet Cell Genet 1996; 73: 179 – 83.
42. Levine E A, Holzmayer T, Bacus S, Mechetner E, Mera R, Bolliger C, Roninson I B, Das Gupka T K. Evaluation of newer prognostic markers for adult soft tissue sarcoma. J Clin Oncol 1997; 15: 3249 – 57.
43. Licht J D, Ro M, English M A, Grossel M, Hansen U. Se-lective repression of transcriptional activators at a dis-tance by the Drosphila Kruppel protein. Natl Acad Sci USA 1993; 90: 11361 – 5.
44. Lim FL, Soulez M, Koczan D, Thiesen H-J, Knight J C. A KRAB-related domain and a novel transcription repres-sor domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 1998; 17: 2013 – 8.
45. Limon J, Dal Cin P, Sandberg A A. Translocation involving the X chromosome in solid tumors: Presentation of two sarcomas with the t(X;18) (q13,p11). Cancer Genet Cy-togenet 1986; 23: 87 – 91.
46. Mandahl N. Genetics of bone and soft tissue tumors. Adv cancer Res 1996; 69: 63 – 99.
47. Mankin H, Mankin C, Simon M. The hazards of biopsy re-visited. For the members of the Musculoskeletal Tumor Society. J Bone Joint Surg 1996; 78-A: 656 – 63.
48. Meis-Kindblom J M, Stenman G, Kindblom L-G. Differen-tial diagnosis of small round cell tumors. Semin Diagn Pathol. 1996; 13: 213 – 41.
49. Meis-Kindblom J M, Kindblom L-G. Angiosarcoma in soft tissue: a study of 80 cases. Am J Surg Pathol 1998; 6: 683 – 97.
50. Melo J V. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375 – 84.
51. Menendez L R, Brien E, Brien WW. Synovial sarcoma. A clinicopathologic study. Orthop Rev 1992; 21 (4): 465 – 71.
52. Mitchell P J, Tijan R. Transcriptional regulation in mam-malian cells by sequence-specific DNA binding pro-teins. Science 1989; 245: 371 – 8.
53. Moberger G, Nilsonne U, Friberg S. Synovial sarcoma. Acta Orthop Scand 1968; 111: 3 – 38.
54. Mullen J R, Zagars G K. Synovial sarcoma outcome fol-lowing conservation surgery and radiotherapy. Radioth-er Oncol 1994; 33: 23 – 30.
55. Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Man-dahl N, Lundeberg J, Uhlén M, Larsson O. The SYT-SSX1 Variant of Synovial Sarcoma is Associated with High Rate of Tumor Cell Proliferation and Poor Clinical Outcome. Cancer Res 1999; 59: 3180 – 4.
56. Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison be-tween early death and long-term survival. Am J Surg Pathol 1993; 17: 35 – 44.
57. Pack G T, Ariel I M. Synovial sarcoma (malignant synovio-ma). A report of 60 cases. Surgery 1950; 28: 1047 – 84.
58. Rosen G, Forscher C, Lowenbraun S, Eilber F, Eckardt J. Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer 1994; 73: 2506 – 11.
59. Rooser B, Willén H, Hugosson A, Rydholm A. Prognostic factors in synovial sarcoma. Cancer 1989; 63: 2182 – 5.
60. dos Santos N R, de Bruijn D R H, Balemans M, Janssen B, Gartner F, Lopes J M, de Leeuw B, Geurts van Kessel A. Nuclear localization of SYT, SSX and the synovial sar-coma- associated SYT-SSX fusion proteins. Hum Mol Genet 1997; 6: 1549 – 58.
61. Shi R-R, Key M E, Kalra K L. Antigen retrieval in forma-lin-fixed, paraffin-embedded tissues an enhancement method for immunohistochemical staining based on mi-crowave oven heating of tissue sections. Histochem Cy-tochem 1991; 39: 741 – 8.
62. Shirakawa H, Tsuda K, Yoshida M. Primary structure of non-histotone chromosomal protein HMG2 revealed by the nucleotide sequence. Biochemistry 1990; 29: 4419 – 23.
63. Singer S, Baldini E H, Demetri G D, Fletcher J A, Corson J M. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for surviv-al. J Clin Oncol 1996; 14: 1201 – 8.
64. Skytting B T, Bauer H C F, Perfekt R, Huuhtanen R, Alveg-fird T, Berlin O, Gustafson P. Klepp R, Löfvenborg R, Swter G, Trovik C, Wahlström O. Clinical Course in Synovial Sarcoma: a Scandinavian Sarcoma Group Study of 104 Patients. Acta Orthop Scand 1999; 70 (6): 536 – 42.
65. Skytting B T, Meis-Kindblom J M, Larsson O, Virolainen M, Perfekt R, Akerman M, Kindblom L-G. Synovial Sarcoma: Identification of Favorable and Unfavorable Histologic Types — A Scandinavian Sarcoma Group Study of 104 Cases. Acta Orthop Scand 1999; 70 (6): 543 – 54.
66. Skytting B T, Bauer H C F, Perfekt R, Nilsson G, Larsson O. Ki-67 is Strongly Prognostic in Synovial Sarcoma. Analysis Based on 86 Patients from the Scandinavian Sarcoma Group Register. Br J Cancer 1999; 80: 1809 – 14.
67. Skytting B T, Szymanska J, Aalto Y, Lushnikova T, Blom-qvist C, Elomaa I, Larsson O, Knuutila S. Clinical Im-portance of Secondary Aberrations in Synovial Sarcoma Evaluated by Comparative Genomic Hybridization. Cancer Genet Cytogenet 1999; 115: 39 – 46.
68. Skytting B, Nilsson G, Brodin B, Xie Y, Lundborg J, Uhlen M, Larsson O. A novel fusion gene, SYT-55X4, in syn-ovial sacoma. J Natl Cancer Inst 1999; 91: 974 – 5.
69. Szymanska J, Serra M, Skytting B, Larsson O, Virolainen M, Akerman M, Tarkkanen M, Huuhtanen, Picci P, Bac-chini P, Asko-Seljavaara S, Eloma I, Knuutila S. Genetic Imbalances in 67 Synovial Sarcomas Evaluated by Comparative Genomic Hybridization. Genes, Chromo-somes & Cancer 1998; 23: 213 – 9.
70. Turc-Carel C, Dal Cin P, Limon J, Li F, Sandberg A. Trans-location X;18 in synovial sarcoma. Cancer Genet Cyto-genet 1986; 23: 93.
71. Tureci O, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild H-J, Stenner F, Seitz G, Rammensee H-G, Pfre-undschuh M. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996; 56: 4766 – 72.
72. Wadayama B, Toguchida J, Yamaguchi T, Sasaki M S, Ko-toura Y, Yamamuro T. P53 expression and its relation-ship to DNA alterations in bone and soft tissue sarco-mas. Br. J Cancer 1993; 68: 1134 – 9.
73. van de Rijn M, Barr F G, Xiong Q-B, Hedges M, Shipley J, Fisher C. Poorly differentiated synovial sarcoma. An analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol 1999; 23: 106 – 12.
74. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lympho-cytes on a human melanoma. Science 1991; 254: 1643 – 7.
75. Varela-Duran J, Enzinger F M. Calcifying synovial sarco-ma. Cancer 1982; 50: 345 – 52.
76. Wright P H, Sim F H, Soule E H, Taylor W F. J Bone Joint Surg Am 1982; 64: 112 – 22.
77. Wurl P, Taubert H, Meye A, Berger D, Lautenschläger C, Holzhausen H-J, Schmidt H, Kalthoff H, Rath F-W, Dralle H. Prognostic value of immunohistochemistry for p53 in primary soft tissue sarcomas: a multivariate anal-ysis of five antibodies. J Cancer Res Oncol. 1987; 123: 502 – 8.
78. Zehr R J, Bauer T W, Marks K E, Weltevreden A. Ki-67 and grading of malignant fibrous histocytomas. Cancer 1990; 66: 1984 – 90.
79. Zito R A. Synovial sarcoma: an Australian series of 48 cas-es. Pathology 1984; 16: 45 – 52.
80. Zoubek A, Dockhorn-Dworniczak B, Delattre O, Chris-tiansen H, Niggli F, Gatter-Menz I, Smith T L, Jiirgens H, Gadner H, Kovar H. Does Expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996; 14: 1245 – 51.